Young children who received the 4CMenB vaccine as infants to protect against serogroup B meningococcal disease had waning immunity by age 5, even after receiving a booster at age 3 ½, according to new research in CMAJ (Canadian Medical Association Journal)
Serogroup B meningococcal disease is the leading cause of meningitis and blood infections in developed countries. Infants and young children under the age of 5 years are especially at risk, and there is a second peak of cases in the late teenage years.
The multicomponent serogroup B meningococcal (4CMenB) vaccine aims to prevent most cases of serogroup B meningococcal disease and is licensed for use in the European Union, Australia and Canada. In 2014, it was recommended for inclusion in the UK's routine childhood vaccination schedule, and a vaccine campaign using 4CMenB targeting all those under 20 years of age was recently run in the Saguenay-Lac-Saint-Jean region of Quebec. However, the Public Health Agency of Canada currently recommends vaccination only for those in defined high-risk groups.
The study, by researchers from the University of Oxford, United Kingdom, and Novartis, the vaccine manufacturer, looked at antibody levels against 8 strains of serogroup B meningococcus in 5 year-old children who had been vaccinated with the 4CMenB vaccine in early childhood and received their last dose 20 months previously. They found that of children who received the vaccine at age 2, 4, 6, 12 and 40 months, 44%-88% still had protective antibody titres against strains that were directly matched to the vaccine. For children vaccinated later (at ages 40 and 42 months), the percentage with protective antibody titres 20 months after their last dose ranged from 31% to 100%. The study also looked at the side effect profile of giving the vaccine at 5 years of age and found that though pain at the site of the vaccination was common, rates of fever were lower than those in younger children.
"These results...provide important new information about how the persistence, at 5 years of age, of bactericidal activity induced by administration of 4CMenB vaccine differs between test strains and with different vaccination schedules," write the authors.
"Introduction of the 4CMenB vaccine into the UK's routine immunization schedule provides an ideal opportunity to assess the effect of this vaccine in a real-world setting and will guide the implementation of 4CMenB vaccination in Canada and worldwide."
Explore further: AAP approves 2015 vaccine schedule for children, teens
More information: Canadian Medical Association Journal, http://ift.tt/1GLy8Ud
Medical Xpress on facebook
Related Stories
Booster dose of new meningitis vaccine may be beneficial
A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...
Administration of meningococcal vaccine with other routine infant vaccines appears effective
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains ...
Newer meningitis vaccine appears safe and effective for infants
A vaccine not yet licensed in the United States produces immunity against four strains of meningococcal disease and is well tolerated when administered to infants, according to a study in the January 9/16 issue of JAMA.
AAP approves 2015 vaccine schedule for children, teens
(HealthDay)—The 2015 recommended childhood and adolescence immunization schedules have been approved by the American Academy of Pediatrics (AAP) and other medical organizations, according to a policy statement ...
AAP updates recommendations for meningococcal vaccines
(HealthDay)—New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics.
Recommended for you
Chef-enhanced school meals increase healthy food consumption
Schools collaborating with a professionally trained chef to improve the taste of healthy meals significantly increased students' fruit and vegetable consumption, according to a new study led by researchers from Harvard T.H. ...
Majority of new pediatricians satisfied with first jobs
Despite reports indicating job dissatisfaction among some physicians, at least one group of doctors seems to be starting their careers on the right note - pediatricians.
Don't let sweet treats leave a sour taste this Easter
Waking to a chocolate egg or two on Easter Sunday is a pleasure most children look forward to, but parents are advised to be moderate and not shower kids with a mountain of chocolate they will be eating for ...
New growth monitoring tools enable better detection of growth disorders in children
Children's growth disorders can be detected earlier and more efficiently with the help of new growth monitoring tools, according to research from the University of Eastern Finland. These tools include up-to-date growth reference ...
Handheld echocardiography ups rheumatic heart disease detection
(HealthDay)—Handheld echocardiography (HAND) and auscultation improves detection of rheumatic heart disease (RHD) compared with auscultation alone, according to a study published online March 16 in Pediatrics.
Pediatrician gives tips for dealing with diaper rash
Diaper rash may not be a serious condition, but it can be extremely painful. It is common and causes concern for many parents trying to comfort their child.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
Young children who received the 4CMenB vaccine as infants to protect against serogroup B meningococcal disease had waning immunity by age 5, even after receiving a booster at age 3 ½, according to new research in CMAJ (Canadian Medical Association Journal)
Serogroup B meningococcal disease is the leading cause of meningitis and blood infections in developed countries. Infants and young children under the age of 5 years are especially at risk, and there is a second peak of cases in the late teenage years.
The multicomponent serogroup B meningococcal (4CMenB) vaccine aims to prevent most cases of serogroup B meningococcal disease and is licensed for use in the European Union, Australia and Canada. In 2014, it was recommended for inclusion in the UK's routine childhood vaccination schedule, and a vaccine campaign using 4CMenB targeting all those under 20 years of age was recently run in the Saguenay-Lac-Saint-Jean region of Quebec. However, the Public Health Agency of Canada currently recommends vaccination only for those in defined high-risk groups.
The study, by researchers from the University of Oxford, United Kingdom, and Novartis, the vaccine manufacturer, looked at antibody levels against 8 strains of serogroup B meningococcus in 5 year-old children who had been vaccinated with the 4CMenB vaccine in early childhood and received their last dose 20 months previously. They found that of children who received the vaccine at age 2, 4, 6, 12 and 40 months, 44%-88% still had protective antibody titres against strains that were directly matched to the vaccine. For children vaccinated later (at ages 40 and 42 months), the percentage with protective antibody titres 20 months after their last dose ranged from 31% to 100%. The study also looked at the side effect profile of giving the vaccine at 5 years of age and found that though pain at the site of the vaccination was common, rates of fever were lower than those in younger children.
"These results...provide important new information about how the persistence, at 5 years of age, of bactericidal activity induced by administration of 4CMenB vaccine differs between test strains and with different vaccination schedules," write the authors.
"Introduction of the 4CMenB vaccine into the UK's routine immunization schedule provides an ideal opportunity to assess the effect of this vaccine in a real-world setting and will guide the implementation of 4CMenB vaccination in Canada and worldwide."
Explore further: AAP approves 2015 vaccine schedule for children, teens
More information: Canadian Medical Association Journal, http://ift.tt/1GLy8Ud
Medical Xpress on facebook
Related Stories
Booster dose of new meningitis vaccine may be beneficial
A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...
Administration of meningococcal vaccine with other routine infant vaccines appears effective
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains ...
Newer meningitis vaccine appears safe and effective for infants
A vaccine not yet licensed in the United States produces immunity against four strains of meningococcal disease and is well tolerated when administered to infants, according to a study in the January 9/16 issue of JAMA.
AAP approves 2015 vaccine schedule for children, teens
(HealthDay)—The 2015 recommended childhood and adolescence immunization schedules have been approved by the American Academy of Pediatrics (AAP) and other medical organizations, according to a policy statement ...
AAP updates recommendations for meningococcal vaccines
(HealthDay)—New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics.
Recommended for you
Chef-enhanced school meals increase healthy food consumption
Schools collaborating with a professionally trained chef to improve the taste of healthy meals significantly increased students' fruit and vegetable consumption, according to a new study led by researchers from Harvard T.H. ...
Majority of new pediatricians satisfied with first jobs
Despite reports indicating job dissatisfaction among some physicians, at least one group of doctors seems to be starting their careers on the right note - pediatricians.
Don't let sweet treats leave a sour taste this Easter
Waking to a chocolate egg or two on Easter Sunday is a pleasure most children look forward to, but parents are advised to be moderate and not shower kids with a mountain of chocolate they will be eating for ...
New growth monitoring tools enable better detection of growth disorders in children
Children's growth disorders can be detected earlier and more efficiently with the help of new growth monitoring tools, according to research from the University of Eastern Finland. These tools include up-to-date growth reference ...
Handheld echocardiography ups rheumatic heart disease detection
(HealthDay)—Handheld echocardiography (HAND) and auscultation improves detection of rheumatic heart disease (RHD) compared with auscultation alone, according to a study published online March 16 in Pediatrics.
Pediatrician gives tips for dealing with diaper rash
Diaper rash may not be a serious condition, but it can be extremely painful. It is common and causes concern for many parents trying to comfort their child.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment